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1. Introduction 
 
1.1. Introduction into rare diseases 
 
Rare diseases affect only a small percentage of the population. They are defined 
as diseases with smaller incidence than 1:2000 (Kelsall et al., 2013). However a rare 
disease affects nationwide only a few patients, but - due to their thousands of different 
types – altogether they affect a significant portion of the population. Generally little is 
known about these disorders compared to the common ones. They occur rarely in the 
practice of a dentist or other medical practitioner and their research got also less 
attention (Kelsall et al., 2013). However, rare diseases like common ones can cause 
mild, severe or very severe symptoms impairing the quality of the patients’ life 
significantly and causing difficulties in socialization and stigmatization (Kelsall et al., 
2013). 
In opposite with common diseases, which usually show multifactorial etiology 
including environmental, life style and genetic factors in their development, rare 
diseases are usually monogenic ones. Therefore the development of rare diseases is 
mostly determined by the presence or the absence of any causative genetic alteration. 
These specific genetic variations of a certain gene can lead to the consequential failure 
of the translated protein and thus to the development of the disease. According to our 
current knowledge, the number of different human monogenic disorders is estimated to 
be more than 10000 (Kelsall et al., 2013; Orphanet Database; www.orpha.net). 
According to the data of the WHO, the global prevalence of monogenic diseases at birth 
is approximately 10:1000 (Kelsall et al., 2013). These diseases usually follow the rules 
of Mendelian inheritance and show either autosomal or sex chromosome-linked and 
either dominant or recessive mode of transmission.  
In this study, I have investigated four rare diseases – Christ-Siemens-Touraine 
syndrome, Papillon-Lefèvre syndrome, Haim-Munk syndrome and aggressive 
periodontitis type 1 – with overlapping dental symptoms and different skin ones.  
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1.2. Christ-Siemens-Touraine syndrome 
 
Christ-Siemens-Touraine syndrome (OMIM 305100) is a rare ectodermal 
dysplasia characterized by a triad of signs comprising sparse hair (hypotrichosis), 
abnormal or missing teeth (anodontia or hypodontia), and inability to sweat (anhidrosis 
or hypohidrosis). Christ-Siemens-Touraine syndrome has been reported throughout the 
world (Pinheiro et al., 1979). It mainly affects males, heterozygous female carriers 
might show mild symptoms or are completely healthy. The prevalence is estimated 
between 1:100000 and 1:1000000 individuals (Fete et al., 2014).  
 
1.2.1. Clinical symptoms  
 
Ectodermal dysplasias are classified as congenital disorders characterized by 
abnormal development in 2 or more ectodermal structures (hair, nails, teeth, and sweat 
glands) without other systemic findings.  
Christ-Siemens-Touraine syndrome is featured by hypotrichosis of the scalp 
and/or the body hair. In addition, the scalp hair has thin shafts and is lightly pigmented. 
Although hair shafts can be brittle and twisted, these findings are not sufficiently 
sensitive to be of diagnostic benefit (Rouse et al., 2004). Secondary sexual hair – beard, 
axillary and pubic hair – may be more normal.  
Christ-Siemens-Touraine syndrome is also characterized by hypodontia: An 
average of nine permanent teeth develop in individuals with classic form, typically the 
canines and first molars (Lexner et al., 2007). Teeth are often smaller than average and 
have an altered morphology; the anterior teeth frequently have conical crowns.  
The third symptom of the triad is hypohidrosis. Historically, the term 
"anhidrotic" has been defined as the inability to perspire; "hypohidrotic" suggests 
impairment in the ability to perspire. Since most individuals with Christ-Siemens-
Touraine syndrome have at least a limited ability to perspire, the term "hypohidrotic" 
more accurately reflects the condition. 
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1.2.2. Genetic background 
 
The majority of individuals with hypohidrotic ectodermal dysplasia show the X-
linked form. Ectodysplasin A (EDA1; GenBank accession number NM_001399.4) is the 
only gene, in which pathogenic variants are known to cause X-linked hypohidrotic 
ectodermal dysplasia. Pathogenic variants in EDAR, EDARADD and WNT10A genes are 
known to be associated with both autosomal dominant and autosomal recessive forms of 
hypohidrotic ectodermal dysplasia (Cluzeau et al., 2011).  
The EDA1 gene comprises 12 exons and encodes a transmembrane protein, 
which has 391 amino acid residues and a short collagenous domain (Gly-X-Y). 
Ectodysplasin-A is a trimeric type II protein that colocalizes with cytoskeletal structures 
at the lateral and apical surfaces of cells, suggesting that it is a novel member of the 
tumor necrosis factor (TNF)-related ligand family that plays a role in early epithelial-
mesenchyme interactions (Ezer et al., 1999).  
 
1.3. Papillon-Lefèvre syndrome 
 
Papillon-Lefèvre syndrome (OMIM 245000) is a rare ectodermal dysplasia 
characterized by early-onset periodontitis associated with palmoplantar keratoderma. 
Papillon-Lefèvre syndrome has been reported throughout the world in a diverse range of 
ethnic groups and parental consanguinity has been noted in more than 50% of the cases 
(Gorlin et al., 1964). The male to female ratio is 1:1. The prevalence is estimated 
between 1:250000 and 1:1000000 individuals and more than 300 cases have been 
reported worldwide (Gorlin et al., 1964; Haneke et al., 1979).  
 
1.3.1. Clinical symptoms  
 
Papillon-Lefèvre syndrome was first described by Paul-Henri Papillon and Paul 
Lefèvre in 1924 (Papillon and Lefèvre, 1924). The main characteristic features of 
Papillon-Lefèvre syndrome are periodontal inflammation, causing loss of both the 
primary and permanent teeth and symmetrical palmoplantar hyperkeratosis. 
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Periodontitis and gingivitis result in the loss of primary and permanent teeth 
(Gorlin et al., 1964; Toomes et al., 1999; Hewitt et al., 2004; Figure 1.).  
   
 Figure 1. Clinical pictures of the teeth loss of a patient with Papillon-Lefèvre syndrome. 
(a) anterior view, (b) right posterior view, (c) left posterior view (Bhavsar et al., 2013). 
 
Since symptoms appear as the teeth erupt, patients with Papillon-Lefèvre syndrome 
typically report two episodes of gingivitis: the first one at approximately 3 years of age, 
leading to the loss of primary teeth (Lundgren et al., 2004), the second one at 
approximately 15 years of age, resulting in the loss of permanent teeth (Fardal et al., 
1998; Figure 2.). 
 
Figure 2. Orthopantogram of a patient with Papillon-Lefèvre syndrome (Bhavsar et al., 
2013). 
 
Keratoderma in Papillon-Lefèvre syndrome can present in the first three months 
of life, although palmoplantar hyperkeratosis generally first appears in years 1–4 
(Haneke et al., 1979). However, several late-onset variants of Papillon-Lefèvre 
syndrome have also been reported (Bullon et al., 1993; Pilger et al., 2003). Skin 
symptoms include transgrediens spread with hyperkeratosis of palms and soles. Diffuse 
c b a 
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hyperkeratosis is the most commonly observed type; however, the punctuate type occurs 
rarely. Generally, hyperkeratosis in Papillon-Lefèvre syndrome is not severe (Toomes et 
al., 1999; Figure 3.). Psoriasiform lesions may also develop on the elbows, knees and 
knuckles (Toomes et al., 1999). Since skin lesions in Papillon-Lefèvre syndrome are 
similar to Mal de Meleda (OMIM 248300) lesions, another rare form of palmoplantar 
keratodermas, Papillon-Lefèvre syndrome was first considered as a variant of Mal de 
Meleda. Subsequently, it was determined that the two diseases are different forms of 
palmoplantar keratodermas (Gorlin et al., 1964).  
In addition to these symptoms, recurrent skin infections and liver abscesses are 
frequently reported (Pham et al., 2004; de Haar et al., 2004; Romero-Quintana et al., 
2013). Moreover mild mental retardation, intracranial calcifications and hyperhidrosis 
can also occur (Haneke et al., 1979). Japanese patients might have an increased risk of 
developing melanomas at the sites of hyperkeratosis (Nakajima et al., 2008) than other 
ethnic groups.  
 
 
 
 
 
 
 
 
 
 
Figure 3. Skin symptoms of a patient with Papillon-Lefèvre syndrome (a,b) palmar 
keratoderma (c,d) plantar keratoderma (Khan et al., 2012). 
 
1.3.2. Genetic background 
 
Papillon-Lefèvre syndrome is transmitted as an autosomal recessive condition 
affecting males and females equally. Papillon-Lefèvre syndrome was independently 
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mapped to chromosome 11q14-21 by three groups (Laass et al., 1997; Fischer et al., 
1997; Hart et al., 1998; Figure 4.). In the mapped region, the causative cathepsin C gene 
was independently identified by two groups (Hart et al., 1999; Toomes et al. 1999). The 
cathepsin C gene (CTSC, GenBank accession number NM_001814.4) spans over 46 kb 
and contains 7 exons and 6 introns (Toomes et al., 
1999). According to the Ensemble genome browser 
(http://www.ensembl.org), this gene has nine splice 
variants. Of these, five occur in protein coding 
regions; the remaining four are non-coding 
transcripts. 
CTSC encodes the cathepsin C protein 
(dipeptidyl-peptidase I), a lysosomalexo-cysteine 
proteinase belonging to the peptidase C1 family. 
Cathepsin C is an oligomeric enzyme composed of 
four identical subunits (Paris et al., 1995; Dolenc et 
al., 1995). Each subunit contains three different 
polypeptides — heavy, light and propeptide chains 
— which are held together by non-covalent 
interactions (Cigic et al., 1998). The C-terminus of 
the propeptide is cleaved upon activation. The 
residual propeptide is cleaved into two peptides, which are held together by a disulphide 
bond (Cigic et al., 1998). 
Cathepsin C has the ability to remove dipeptides from the amino terminus of 
proteins and is involved in the zymogen activation of serine proteases. This activity was 
proposed to play a role in epithelial differentiation and desquamation (Toomes et al., 
1999). 
 
1.4. Haim-Munk syndrome 
 
Haim-Munk syndrome (OMIM 245010) is a rare ectodermal dysplasia 
characterized by early-onset severe periodontitis associated with palmoplantar 
Figure 4. Location of the CTSC 
gene on chromosome 11 
(www.ncbi.nlm.nih.gov/gene/1075). 
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keratoderma, onychogryposis, pes planus, arachnodactyly and acroosteolysis (Haim and 
Munk, 1965). The majority of reported cases are descendants of a few consanguineous 
families from a religious isolate in Cochin, India (Haim and Munk, 1965; Smith and 
Rosenzeig, 1967; Puliyel and Sridharan Iyer, 1986). One unrelated Brazilian patient has 
also been reported (Cury et al., 2005). The male to female ratio is 1:1. The prevalence is 
estimated to be 1:1000000 individuals. Haim-Munk syndrome is very rare with less than 
100 cases reported in the literature so far (Haim and Munk, 1965; Smith and Rosenzeig, 
1967; Puliyel and Sridharan Iyer, 1986; Cury et al., 2005).  
 
1.4.1. Clinical symptoms 
 
Haim-Munk syndrome was first described among members of a small 
community of Jews from Cochin, India by Haim and Munk (1965). The main 
characteristic features of Haim-Munk syndrome are periodontitis associated with 
palmoplantar keratosis, pes planus, onychogryphosis, arachnodactyly and acroosteolysis.  
The periodontium in Haim-Munk syndrome may be less severely affected than in 
Papillon-Lefèvre syndrome, but gingival inflammation and alveolar-bone destruction are 
present and severe (Janjua et al., 2004; Figure 5.). 
   
Figure 5. Dental symptoms of a patient with Haim-Munk syndrome. (a) The gingiva 
around the teeth is bright red, severely inflamed, swollen, with pus exuding from the 
periodontal pockets and gingival abscesses. (b) The panoramic radiographs shows 
severe vertical and horizontal alveolar bone loss around all remaining teeth (Erciyas et 
al., 2010). 
 
  
 b 
b a 
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In contrast to Papillon-Lefèvre syndrome, the cutaneous findings in Haim-Munk 
syndrome are more severe and extensive (Hartc et al., 2000). Besides palmoplantar 
hyperkeratosis, there are several additional features including recurrent pyogenic skin 
infections, acroatrophic changes of nails, arachnodactyly, a peculiar radiographic 
deformity of the finger contapered, pointed phalangeal ends, and pes planus (Janjua et 
al., 2008; Figure 6.). 
 
Figure 6. Arachnodactyly and acroosteolysis detected in patient with Haim-Munk 
syndrome (Erciyas et al., 2010).  
 
1.4.2. Genetic background 
 
Haim-Munk syndrome is transmitted as an autosomal recessive condition 
affecting males and females equally. Similarly to Papillon-Lefèvre syndrome, Haim-
Munk syndrome is also caused by mutations of the CTSC gene (Hartc et al., 2000). 
 
1.5. Aggressive periodontitis type 1 
 
Aggressive periodontitis type 1 (OMIM 170650) is a rare ectodermal dysplasia 
characterized by severe periodontal inflammation leading to tooth loss (Hart et al., 
2000c; Hewitt et al., 2004). Since other organs are not affected, aggressive periodontitis 
type 1 also belongs to the family of non-syndromic aggressive periodontitis. There are 
only a few cases in the literature, which are genetically confirmed and diagnosed as 
aggressive periodontitis type 1 (Hart et al., 2000c; Hewitt et al., 2004). Regarding these 
patients, the male to female ratio is 1:1. The prevalence is estimated to be less than 
1:1000000 individuals (Hart et al., 2000c; Hewitt et al., 2004).  
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1.5.1. Clinical symptoms 
 
Aggressive periodontitis, which may be generalized or localized, is characterized 
by severe and protracted gingival infections, leading to tooth loss. Amounts of microbial 
deposits are generally inconsistent with the severity of periodontal tissue destruction and 
the progression of attachment and bone loss may be self-arresting (American Academy 
of Periodontology, 2000). The term “aggressive periodontitis” replaced the terms “early-
onset,” “prepubertal,” or “juvenile periodontitis” at a 1999 International workshop for a 
classification of periodontal disease and conditions, where it was decided that the 
classification terminology should not be age dependent or require knowledge of rates of 
progression (Armitage, 1999). 
Aggressive periodontitis type 1 is usually characterized by dental symptoms only 
and other organs are not affected. The main feature of aggressive periodontitis type 1 is 
the severe periodontal inflammation leading to tooth loss (Hart et al., 2000c; Hewitt et 
al., 2004; Figure 7.).   
    
Figure 7. Patient with aggressive periodontitis type 1. (a) Clinical and (b) X-ray 
pictures demonstrate gingival recession and advanced alveolar bone loss around 
remaining primary dentation (Hart et al., 2000c).  
 
1.5.2. Genetic background 
 
Aggressive periodontitis type 1 is transmitted as an autosomal recessive 
condition affecting males and females equally. Similarly to Papillon-Lefèvre and Haim-
a b 
b a 
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Munk syndromes, aggressive periodontitis type 1 is also caused by mutations of the 
CTSC gene (Hart et al., 2000c). 
 
1.6. Same cause, same disease 
 
Papillon-Lefèvre syndrome, Haim-Munk syndrome and aggressive periodontitis 
type 1 have some overlapping and some distinctive clinical features, therefore earlier 
they were considered as different entities. In 1999, with the identification of their 
causative gene, the CTSC gene, their common genetic background was identified (Hart 
et al., 1999; Toomes et al., 1999). First it was suggested that different mutations of the 
CTSC gene might lead to the development of different disease, but genotyping patients 
with Papillon-Lefèvre syndrome, Haim-Munk syndrome or aggressive periodontitis type 
1 did not confirm this hypothesis.   
To date, a total of 75 mutations have been reported for the CTSC gene. The 
majority of the mutations (97%) were reported in patients with Papillon-Lefèvre 
syndrome, while only a few mutations (3%) were reported in patients with either Haim-
Munk syndrome or aggressive periodontitis type 1.  
To note, some mutations of the CTSC gene were detected in two different disease 
entities: The c.1040A>G p.Tyr347Cys missense mutation was reported in patients with 
aggressive periodontitis type 1 and also in patients with classic Papillon-Lefèvre 
syndrome (Toomes et al., 1999; Hart et al., 2000c; Hewitt et al., 2004). The c.145C>T 
p.Gln49X nonsense mutation was reported for Haim-Munk syndrome and for Papillon-
Lefèvre syndrome pedigrees (Selvaraju et al., 2003; Rai et al., 2010). The c.857A>G 
p.Gln286Arg missense mutation was present in patients with the phenotype of either 
Haim-Munk syndrome or Papillon-Lefèvre syndrome (Hart et al., 2000b). These genetic 
findings suggest, that Papillon-Lefèvre syndrome, Haim-Munk syndrome and aggressive 
periodontitis type 1 are not different entities, but they represent the phenotypic spectrum 
of a single disease (Table I.). Therefore in the followings, the diagnosis of Papillon-
Lefèvre syndrome is used in this study. 
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Papillon-Lefèvre 
syndrome 
Haim-Munk 
syndrome 
Aggressive 
periodontitis type 1 
OMIM ID 245000 245010 170650 
Clinical symptoms 
Periodontitis 
   
Palmoplantar 
keratoderma    
Pes planus 
   
Onychogryphosis 
   
Arachnodactyly 
   
Acroosteolysis 
   
Genetic background 
CTSC mutations 
   
Table I. Comparison of the clinical features and genetic background of Papillon-
Lefèvre syndrome, Haim-Munk syndrome and aggressive periodontitis type 1. 
 
1.7 Aims 
 
In this study, I have investigated the Christ-Siemens-Touraine syndrome and the 
allelic variants of Papillon-Lefèvre syndrome, which include Haim-Munk syndrome and 
aggressive periodontitis type 1. These variants show overlapping dental symptoms and 
different other ones.  
I aimed to investigate Hungarian pedigrees and sporadic cases with Papillon-
Lefèvre syndrome. After performing the relevant, adequate dental care for these patients, 
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I have initiated dermatological investigations to perform complete workup for these 
patients.  
Besides the teamwork of the clinical care, I have also initiated genetic screening 
for these patients to help them in family planning and also to elucidate the genotype-
phenotype correlations of the disease. Therefore I aimed to compare the clinical 
symptoms and the identified mutations in all investigated patients. After comparing 
Hungarian patients to each other, I have also compared their data with the so far reported 
ones in the literature. To do this, I have performed literature search 
(http://www.ncbi.nlm.nih.gov/pubmed) to identify the reported patients Papillon-Lefèvre 
syndrome and all the known CTSC mutations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
 
2. Patients and methods 
 
2.1. Patients 
 
However Christ-Siemens-Touraine and Papillon-Lefèvre syndrome are rare 
diseases, there are several patients under my dental care. In this study, I will describe 
three families and two sporadic cases in details, in whom the genetic investigations 
identified the causative abnormalities.  
In Hungary, mutation screening for the EDA1 and CTSC genes have been 
available since 2011. Screening is performed with direct sequencing of all coding 
regions and flanking introns of the EDA1 and CTSC genes. Once a putative causative 
variant was identified in a patient, the available, clinically symptom-free family 
members and unrelated, healthy control individuals were also investigated. 
 
2.1.1. Pedigree I 
 
I have recently identified a 35-year-old Hungarian patient with Christ-Siemens-
Touraine syndrome and with characteristic dysmorphic facial features, sparse hair, 
reduced sweating and missing teeth (Figure 8.). 
 
Figure 8. Clinical symptoms of the patient with Christ-Siemens-Touraine syndrome: (a) 
missing eyebrows and eyelashes, (b) sparse hair and (c) hypodontia (Kinyo et al., 2014).   
 
a b c 
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On investigation the classic triad of Christ-Siemens-Touraine syndrome was 
present. Dermatological symptoms included sparse hair and reduced sweating and dental 
symptoms highlighted hypodontia.  
The investigated patient (II/3) is the only affected family member who exhibits 
the complete triad with sparse hair, missing teeth and reduced sweating. His sister (II/2) 
and his daughter (III/1) also have some conical-shaped teeth, but otherwise they are 
healthy. The older brother of the patient (II/1) died at the age of 4 months due to 
hyperpyrexia. The symptomless parents reported on a 16-year-old sister of the affected 
daughters, who has no symptoms as well as the parents (Kinyo et al., 2014; Figure 9.). 
 
Figure 9. Pedigree of the investigated family spreading three generations and 
containing one affected individual (Kinyo et al., 2014). 
 
 
2.1.2. Pedigree II 
 
I have recently identified a Hungarian family with two sisters affected with 
severe periodontitis leading to the loss of all primary teeth (Figure 10.). a b 
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Figure 10. X-ray pictures show the dental symptoms of the older one (Patient I) of the 
siblings affected by Papillon-Lefèvre syndrome. (a) The first picture was taken in 2006, 
(b) the second one in 2011.   
 
On dermatological investigation an 11-year-old Hungarian girl (Patient I) was 
referred with the typical skin symptoms of Papillon-Lefèvre syndrome, complicated with 
palmoplantar eruption. On referral sharply circumscribed erythema with minimal 
hyperkeratosis and shedding was seen on both palms (Farkas et al., 2013; Figure 11).  
 
Figure 11. Palmar skin symptoms of the two investigated siblings affected by Papillon-
Lefèvre syndrome: (a) Patient I, (b) Patient II (Farkas et al., 2013). 
  
The erythema on the plantar surfaces was minimal, however hyperkeratosis with deep 
fissures dominated (Farkas et al., 2013; Figure 12). These abnormalities first appeared at 
her age of 19 months (Farkas et al., 2013).  
a b 
b a 
b a 
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 Figure 12. Plantar skin symptoms of the two investigated siblings affected by Papillon-
Lefèvre syndrome: (a) Patient I, (b) Patient II (Farkas et al., 2013).   
 
The other patient (Patient II) was a 2-year-old Hungarian girl, the younger sister 
of Patient I. She was also referred with having similar symptoms as her older sibling. 
Palmoplantar eruptions started at her age of 10 months. On referral, minimal erythema 
was seen on the distal fingertips (Farkas et al., 2013; Figure 9.) and erythema with 
minimal hyperkeratosis was present on the soles of the feet (Farkas et al., 2013; Figure 
10.). 
The symptomless parents reported on a 16-year-old sister of the affected 
daughters, who has no symptoms as well as the parents (Farkas et al., 2013; Figure 13.). 
 
Figure 13. Pedigree of the investigated family spreading two generations and 
containing two affected siblings (Farkas et al., 2013). 
 
 
 
a b 
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2.1.3. Pedigree III 
 
There is another pair of affected siblings, who are also under my regular dental 
care. In this Hungarian family the affected two sisters were referred to our out-patient 
dental clinic years ago with severe tooth loss due to severe periodontitis (Figure 14.).  
 
Figure 14. Orthopantograms show dental symptoms of the affected siblings, (a) Patient 
I, (b) Patient II. 
Regarding their dermatological symptoms, there is a significant contrast between 
the severity of the palmar and the plantar hyperkeratosis. The sisters show very mild 
palmar symptoms on both hands, it looks like hand dryness (Figure 15.).  
   
 
 
 
 
 
   
Figure 15. Palmar skin symptoms of the two investigated siblings affected by Papillon-
Lefèvre syndrome: (a) left and (b) right hand of Patient I, (c) left and (d) right hand of 
Patient II. 
a b 
a b c d 
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In opposite with their hands, the hyperkeratosis on their soles is very severe 
(Figure 16.).  
 
Figure 16. Plantar skin symptoms of the two investigated siblings affected by Papillon-
Lefèvre syndrome: (a) right and (b) left feet of Patient I, (c) right and (d) left feet of 
Patient II. 
 
The symptomless parents reported on having no other affected or symptomless 
child. Since these siblings are now young adults, Patient I is 24 and Patient II is 28-
yeard-old. I have performed dental investigations and complete clinical and genetic 
workup for their symptomless partners as well (Figure 17.). 
 
Figure 17. Pedigree of the investigated family spreading two generations and 
containing two affected siblings. 
 2.1.4. Sporadic case I 
 
A 39-year-old Hungarian woman was referred from the Mór Kaposi Teaching 
Hospital (Kaposvár) with a common phenotype of Papillon-Lefèvre syndrome. The 
patient was presented with the typical skin symptoms of Papillon-Lefèvre syndrome. 
She has lost all her permanent teeth and has permanent prosthesis. Hyperkeratotic 
plaques were seen on both palms and soles (Figure 18). Besides these symptoms, 
arachnodactily was also present on the right hand raising the possibility of the allelic 
variant of the Papillon-Lefèvre syndrome, the Haim-Munk syndrome (Figure 18). 
a b c d 
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Figure 18. Clinical symptoms of the patient affected by Haim-Munk syndrome, the 
allelic variant of Papillon-Lefèvre syndrome: (a) mild palmar hyperkeratosis, (b) 
arachnodactily and (c) moderate hyperkeratosis of the palms. 
 
2.1.5. Sporadic case II 
 
A 25-year-old Hungarian man unrelated to the previous 39-year-old Hungarian 
woman. He was also referred from the Mór Kaposi Teaching Hospital (Kaposvár) with 
complete teeth loss and hyperkeratotic skin symptoms on his palms and soles. He does 
not show arachnodactily (Figure 19.). 
 
Figure 19. Clinical symptoms of the patient affected by Papillon-Lefèvre syndrome: (a) 
mild palmar hyperkeratosis, (b) no sign of arachnodactily and (c) moderate 
hyperkeratosis of the palms. 
a b c 
a b c 
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2.2. Methods 
 
All patients are in complete clinical care including dental and dermatological 
care. Written informed consents were obtained from all investigated individuals during 
pre-test genetic counselling before genetic investigations were carried out. The 
investigated individuals were informed about the results of the investigations during 
post-test genetic counselling. The study was conducted according to the Principles of the 
Declaration of Helsinki.  
 
2.2.1. DNA isolation 
 
Blood samples were taken from the patients and from the clinically unaffected 
family members (Figure 20.). Genomic DNA was isolated from whole blood samples 
using a QIAamp DNA Blood Mini Kit (QIAGEN; Hilden, Germany). During the 
isolation, after proteinase K digestion, washings with alcohol were done following the 
instructions. Genomic DNA was dissolved in 100 μl distilled water. 
 
2.2.2. Polymerase chain reaction  
 
During polymerase chain reaction (PCR) amplification (Figure 20.), 4 μl 
genomic DNA was used as template. In addition, the reaction mix contains 9 μl Dream 
Taq Green PCR Master Mix (Fermentas), 4 μl distilled water, 1.5 μl forward and 1.5 μl 
reverse primers. The using primers sequences obtained from the UCSC Genome 
Browser and Primer3 and listed in Table II. 
During PCR reaction, the 2nd, 3rd and 4th steps were repeated 40 times. The 
annealing temperature and the number of the cycles were depended on the primers, the 
synthesis reaction time was determined according to the length of the reaction product. 
PCR reaction was carried out with the conditions listed in Table III. 
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Primer 5'-3' sequence  
CTSC-X1-F CTCGGCTTCCTGGTAATTCTT 
CTSC-X1-R GAAGCGGTAGTTGGCGTG 
CTSC-X2-F CAAACTGGGTAGCATGAAAGG 
CTSC-X2-R GAGTGGTGTCAATTCCGGTC 
CTSC-X3-F GCCATGGAAATGGACCTG 
CTSC-X3-R TGGTCCATTACTTTTGGAACACT 
CTSC-X4-F GCACAGAGTGTGAATGCCTG 
CTSC-X4-R AGGACTGCTTAGGAGGGAGG 
CTSC-X5-F GGAAATCATCCTCAAAGGAAAG 
CTSC-X5-R GTATCCCCGAAATCCATCAC 
CTSC-X6-F TGCATGATTCTCTGTGAGGC 
CTSC-X6-R GGCCAGACTTGCACTCAGAT 
CTSC-X7a-F TTCAGGGGTAACATGCAAAG 
CTSC-X7a-R CATAGCCCACAAGCAGAACA 
CTSC-X7b-F CTGCAATGAAGCCCTGATG 
CTSC-X7b-R GATTGCTGCTGAAAGTCTACAGTC 
Table II. The list of primers used for the genetic investigations. 
 
   
Step Temperature (oC) Time (sec) Process 
I. 95 600  
II. 95 30 denaturation 
III. 59 30 annealing 
IV. 72 45 synthesis 
V. 72 600  
VI. 4 ∞  
Table III. Conditions of the PCR reactions. 
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2.2.3. Gel electrophoresis  
 
The PCR products were checked on 2% agarose gel (SeaKem LE agaróz, Lonza) 
using TBE buffer (Lonza) and visualized by 2.5 μl GelRed (Biotium) staining (Figure 
18.). The gel was analyzed by BioRad Molecular Imager® GelDoc™ XR gel 
documentation system with QuantityOne software.  
 
2.2.4. Sequencing 
 
The sequencing was performed after the suitable purifying of the PCR reaction 
products using Big Dye Terminator v3.1 Cycle sequencing kit (Applied Biosystems) 
with ABI Prism 7000 (Applied Biosystems) sequencing machine (Figure 18.). The 
service of the sequencing was offered by Delta Bio 2000 Kft. 
 
 
Figure 20. Summary of the applied genetic investigations. Blood samples were taken 
from all investigated individuals, then DNA was isolated. Using specific primers PCR 
reactions were carried out. The PCR products were checked on agarose (1.5%) gel 
electrophoresis and then they were sequenced. 
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3. Results 
 
3.1. Patient in Pedigree I carried hemizygous missense mutation 
 
Direct sequencing of the coding regions and the flanking introns of the EDA1 
gene revealed a novel missense mutation in the eight exon (c.971T/A, p.Val324Glu; 
Figure 21.). The investigated healthy controls carried only wild-type sequences.  
 
Figure 21. The identified hemizygous missense mutation in the patient with Christ-
Siemens-Touraine syndrome (Kinyo et al., 2014).  
 
The identified p.Val324Glu missense mutation is located in the TNF domain of 
the ectodysplasin protein. Therefore this genetic variant may affect the 
ectodysplasin/NFκB signaling pathway.  
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3.2. Patients in Pedigree II carried homozygous deletion 
 
Direct sequencing of the coding regions and the flanking introns of the CTSC 
gene revealed a seven-base deletion in the fourth exon (c.566delCATACAT, 
p.T189fsX199; Figure 22.). This deletion causes frameshift and leads to the 
development of a premature termination codon (TGA) 32 bases downstream of the 
mutation.  
 
 
Figure 22. The identified homozygous seven-base deletion in the patients of Pedigree II.  
 
The patients carried the mutation in homozygous form (Farkas et al., 2013; 
Figure 23.), while the unaffected family members – the parents and the symptomfree 
sister – carried the same mutation in heterozygous form (Farkas et al., 2013; Figure 23.). 
The unrelated controls carried the wild type sequence. The family was not aware of 
consanguinity.  
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Figure 23. Summary of the results of the genetic investigations.  
 
This frameshift mutation has also been previously published for two Moroccan 
patients with Papillon-Lefèvre syndrome (Noack et al., 2008; Figure 24.). 
       
 
Figure 24. The identified deletion was reported also in Moroccan patients. 
 
  3.3. Patients in Pedigree III carried homozygous missense mutation 
 
 Direct sequencing of the coding regions and the flanking introns of the CTSC 
gene revealed a missense mutation in the seventh exon (c.901G/A, p.G301S; Figure 25.). 
This missense mutation causes amino acid change in the cathepsin C protein.  
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Figure 25. The identified homozygous missense mutation in the patients of Pedigree III.  
 
The patients carried the mutation in homozygous form (Figure 26.), while the 
symptomfree partners of the patients carried the wild type sequence. The unrelated 
controls carried the wild type sequence as well. The family was not aware of 
consanguinity.  
 
   
Figure 26. Summary of the results of the genetic investigations. 
 
This mutation has also been previously published for a German patient with 
typical Papillon-Lefèvre syndrome (Noack et al., 2008; Figure 27.) 
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Figure 27. The identified missense mutation was previously reported in German 
patients (Noack et al., 2008). 
 
3.4. The unrelated cases carried the same nonsense mutation  
 
 In a pair of unrelated Hungarian patients with Papillon-Lefèvre syndrome, we 
have identified a nonsense mutation in the fifth exon (c.748C/T, p.R250X; Figure 28.) 
using direct sequencing of the coding regions and the flanking introns of the CTSC gene. 
This missense mutation causes truncation of the cathepsin C protein.  
    
 
Figure 28. The identified homozygous nonsense mutation in the unrelated patients with 
Papillon-Lefèvre syndrome.  
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Unfortunately, both of these patients were grown up in state care and not aware 
of any known relatives; therefore, investigation of the family was not possible. The fact 
that both individuals carry the same mutation raises the possibility that these patients 
somehow are relatives. This mutation has also been previously published in the literature 
in a Turkish family with Papillon-Lefèvre syndrome (Hart et al., 2000a; Figure 29.). 
 
Figure 29. The identified nonsense mutation was previously reported in Turkish patients 
(Hart et al., 2000a). 
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4. Discussion  
4.1. Significance of the investigations in the EDA1 gene 
My investigations have identified a novel hemizygous missense mutation 
(c.971T/A, p.Val324Glu) of the EDA1 gene in a Hungarian patient with Christ-Siemens-
Touraine syndrome.  
It is interesting to note that previous studies have reported missense EDA1 
mutations in non-syndromic tooth agenesis, suggesting that dental tissues are 
particularly sensitive to ectodysplasin protein abnormalities (Tao et al., 2006; Li et al., 
2008). These previous findings are in good accordance with our data, as the sister and 
the daughter of the investigated patient, both of whom are heterozygous carriers of the 
identified mutation, have some conical-shaped teeth, but exhibit otherwise normal 
phenotype. The investigated male patient, who is a hemizygous carrier of the mutation, 
shows full expression of the Christ-Siemens-Touraine phenotype with severe dental 
abnormalities: he developed only seven permanent, conical-shaped teeth and thus 
currently uses a permanent dental prosthesis.  
Since the novel hemizygous missense mutation (c.971T/A, p.Val324Glu) is 
located in a highly conserved region within the TNF domain of the ectodysplasin protein 
(Figure 30.), it is hypothesized that this mutation affects the NFκB signaling pathway.  
 
 
 
 
Figure 30. The identified novel missense mutation is located in the TNF domain of the 
ectodysplasin A protein (Kinyo et al., 2014). 
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4.2. Variants in the CTSC gene 
To date, a total of 75 mutations have been identified for the CTSC gene (Figure 
31.). Mutations are named according to Human Genome Variation Society (HGVS) 
nomenclature guidelines (www.HGVS.org) and numbered with respect to the CTSC 
gene reference sequence (ENSG00000109861 corresponding to the CTSC gene 
transcript ENST00000227266).  
   
Figure 31. Schematic drawing of the CTSC gene, indicating the positions of mutations 
leading to Papillon-Lefèvre syndrome, Haim-Munk syndrome and aggressive 
periodontitis type 1. Identical mutations can lead to different diseases. The involvement 
of mutations in specific diseases is indicated as follows: #, Papillon-Lefèvre syndrome 
and Haim-Munk syndrome; *, Papillon-Lefèvre syndrome and aggressive periodontitis 
type 1; †, Haim-Munk syndrome; ‡, common missense variants reported as causative for 
Papillon-Lefèvre syndrome (Nagy et al., 2014). 
 
Of the reported 75 mutations, 53% are missense (n=40), 23% are nonsense 
(n=17) and 17% are frameshift (n=13) variants. There are two in-frame deletions, one 
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intronic splice-site variant and one point mutation in the 5' untranslated region of the 
CTSC gene. The majority (75%, n=56) of the mutations has only been reported once. 
Among these, 65% (n=36) were present in homozygous form in the investigated 
patients, while 35% (n=20) occurred in a compound heterozygous form. Recurrent 
mutations (25% of all mutations, n=19) occurred both in homozygous and in compound 
heterozygous forms and were detected in geographically distant, unrelated families, 
suggesting mutational clustering on the CTSC gene. However, there are also examples in 
the literature describing that the same initial founder effect and the subsequent migration 
of carriers can lead to the presence of the same mutation in geographically distant and 
unrelated families (Zhang et al., 2001; Kurban et al., 2009). 
The known mutations, that have been sequenced, are unequally distributed on the 
CTSC gene. Half of the mutations (53%, n=41) are located within exons 5–7, encoding 
amino acids 231 to 394 in the heavy chain region. Of the remaining half, 16% (n=12) are 
located within exons 1–3 encoding amino acids 25 to 134 in the exclusion domain, 12% 
(n=9) are located within the second half of exon 7 encoding amino acids 395 to 463 in 
the light chain region, 13% (n=10) are located within exon 4 and the first half of exon 5 
encoding amino acids 135 to 230 in the propeptide region, 3% (n=2) are located in the 5' 
end of exon 1 encoding amino acids 1 to 24 in the signal peptide region and 3% (n=2) 
are located within untranslated regions.  
 
4.3. Ethnic variation 
 
Papillon-Lefèvre syndrome has been reported in a diverse range of ethnic groups 
from all over the world. A quarter (25%, n=19) of the mutations have been reported 
twice or more in different ethnic groups. One of the most frequently reported missense 
mutation, the c.815G>Cp.Arg272Pro variant, has been detected in Lebanese, Turkish, 
Saudi, Holland, Russian and French patients (Toomes et al., 1999, Lefevre et al., 2001, 
Zhang et al., 2002, Pham et al., 2004, de Haar et al., 2004, Noack et al., 2008), while 
another frequent nonsense mutation, c.96T>Gp.Tyr32X, has been observed in patients 
from Mexico and France (Lefevre et al., 2001, Zhang et al., 2002, Pham et al., 2004).  
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Mutation on 
Allele 1
Mutation type
Mutation on 
Allele 2
Mutation type References
c.380A>C 
p.His127Pro
missense
c.815G>A 
p.Arg272His
missense
c.436delT 
p.Ser146fsX30
frameshift
c.504C>G 
p.Tyr168X
nonsense
c.72C>A 
p.Cys24X
nonsense
c.706G>T 
p.Asp236Tyr
missense
c.778T>C 
p.Ser260Pro
missense
c.1141delC 
p.Leu381fsX13
frameshift
c.415G>A 
p.Gly139Arg
missense
c.872G>A 
p.Cys291Tyr
missense
c.96T>G 
p.Tyr32X
nonsense
c.1141delC 
p.Leu381fsX13
frameshift
c.415G>A 
p.Gly139Arg
missense
c.815G>C 
p.Arg272Pro
missense
c.815G>C 
p.Arg272Pro
missense
de Haar et al., 2004; 
Lefevre et al., 2001; 
Noack et al., 2008; 
Pham et al., 2004; 
c.1141delC 
p.Leu381fsX13
frameshift Lefevre et al., 2001
c.415G>A 
p.Gly139Arg
missense
Cagli et al., 2005; 
Hewitt et al., 2004; 
Yang et al., 2007
c.706G>T 
p.Asp236Tyr
missense
Allende et al., 2001; 
Hewitt et al., 2004
c.96T>G 
p.Tyr32X
nonsense
Lefevre et al., 2001; 
Pham et al., 2004; 
Zhang et al., 2002
c.322A>T 
p.Lys108X
nonsense Noack et al., 2008
 
Table IV. The most frequent compound heterozygous pathogenic combinations of CTSC 
mutations. 
 
Moreover, a common frameshift mutation, c.566delCATACAT p.Thr189fsX200, has 
been found in Hungarian and Moroccan patients (Noack et al., 2008, Farkas et al., 
2013). Haplotype analyses of different cases carrying identical mutations revealed that 
these relatively frequent mutations resulted from independent founder events. Two 
Turkish families carrying the same homozygous nonsense mutation (c.856C>T 
p.Gln286X exhibited different haplotypes, suggesting that the same mutation arose in 
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the two families independently (Hart et al., 1998 and 2000a). The most common 
mutations are summarized in Table IV. 
 
4.4. Biological relevance 
 
Cathepsin C is a lysosomal cysteine protease that was first characterized as an 
activator of serine proteases from immune and inflammatory cells (Turk et al., 2001). 
Cell lines derived from cathepsin-C-deficient mice fail to activate groups of serine 
proteases. Unprocessed proteases zymogens included granzymes A, B and C, cathepsin 
G, neutrophil elastase and chymase (Adkinson et al., 2002). 
The encoded cathepsin C precursor contains 463 amino acids and includes a 
signal peptide (24 amino acids), an exclusion domain (110 amino acids), a propeptide 
(96 amino acids), as well as heavy (164 amino acids) and light (69 amino acids) chain 
regions (Turk et al., 2001; Hewitt et al., 2004). Precursor cathepsin C is processed into 
the mature form by at least four cleavages of the polypeptide (Turk et al., 2001; 
Adkinson et al., 2002). The signal peptide is removed during translocation or secretion 
of the protein (Turk et al., 2001; Adkinson et al., 2002). The exclusion domain is 
retained in the mature enzyme and separated from the heavy and light chains by excision 
of a minor C-terminal portion of the propeptide region. The heavy and light chains are 
also generated by cleavage (Turk et al., 2001; Adkinson et al., 2002). 
According to a BLAST (http://blast.ncbi.nlm.nih.gov/) search, the cathepsin C 
protein is highly conserved in vertebrates: the human cathepsin C shows 82% sequence 
similarity with the sequence from dog, 70% with turkey and 63% with frog and 
zebrafish. The most highly conserved regions are the heavy chain, the light chain and the 
C-terminal portion of the exclusion domain, which is thought to be important for 
enzyme activity.  
Half (53%, n=40) of all CTSC gene mutations affect the heavy chain domain and 
result in different positioning of its N-terminus. Since the N-terminal region is involved 
in oligomer contacts with the N-terminal region of the light chain, the mutation may 
interfere with tetramer formation (Turk et al., 2001). This finding indicates that 
tetramerization of the cathepsin C enzyme is crucial for its function. The majority of the 
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two most common types of CTSC mutations (missense and nonsense) affect this domain 
(Figure 28.). 
Sixteen percent (n=12) of all CTSC mutations affect the exclusion domain, which 
blocks access to the active site and prevents substrates from binding any part except 
their N-termini. Thirteen mutations were detected in the exclusion domain; of these, six 
are nonsense variants, four are missense mutations, and three are deletions (two resulting 
in frameshift and one in an in-frame deletion). 
Thirteen percent (n=10) of all CTSC gene mutations affect the propeptide 
fragment, which plays a pivotal role in the activation of the cathepsin C precursor. The 
majority of frameshift mutations are located in this domain (Figure 32.). 
 
Figure 32. Distribution of mutations on the cathepsin C protein: (a) missense, (b) 
nonsense and (c) frameshift. 
 
Twelve percent (n=9) of all mutations affect the light chain domain, which is 
important for tetramerization of the mature enzyme: four are missense mutations, two 
are nonsense variants and one is an in-frame deletion. Three common missense variants, 
rs151269219, rs28937571 and rs3888798 are also located in this domain (Nakano et al., 
2001; Hewitt et al., 2004; de Haar et al., 2005; Noack et al., 2008). 
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Three percent (n=3) of all mutations are located in the signal peptide region, 
presumably affecting the translocation or secretion of the protein: one nonsense mutation 
and one frameshift variant (Lefevre et al., 2001; Hewitt et al., 2004; Kurban et al., 
2010). 
 
4.5. Clinical and diagnostic relevance 
 
Historically, Papillon-Lefèvre syndrome was initially considered a variant of Mal 
de Meleda, due to the similarity of the skin lesions. Subsequently, the two diseases were 
determined to be different forms of palmoplantar keratodermas (Gorlin et al., 1964). In 
addition to palmoplantar hyperkeratosis, periodontal inflammation is a main feature of 
Papillon-Lefèvre syndrome. Clinical diagnosis of Haim-Munk syndrome, an allelic 
variant of Papillon-Lefèvre syndrome, is based on the presence of arachnodactly, 
acroosteolysis, pesplanus and onychogryposis in addition to palmoplantar hyperkeratosis 
and periodontal inflammation (Hart et al., 2000b). Aggressive periodontitis type 1, 
which can be also considered a variable expression of the Papillon-Lefèvre syndrome 
phenotype, is characterized by periodontal inflammation and the lack of other 
symptoms. All the three entities develop as a consequence of CTSC mutations. 
Identification of a CTSC mutation gives a definite diagnosis of Papillon-Lefèvre 
syndrome, Haim-Munk syndrome or aggressive periodontitis type 1 depending on the 
presented clinical symptoms. In contrast, the absence of CTSC mutation suggests a 
diagnosis of another palmoplantar keratoderma or non-syndromic tooth abnormality. 
Analysis of data reported worldwide and the findings of the Hungarian patients 
with Papillon-Lefèvre syndrome revealed 75 CTSC gene mutations. The most frequent 
mutations are recurrent and are reported both as homozygous and as compound 
heterozygous. The identification of the most frequent CTSC gene mutations has great 
clinical significance, since they highlight regions of the gene that are important for the 
development of the disease. The most frequent mutations of the CTSC gene and their 
most common associations are summarized in Table IV. The frequency of mutations, 
whether looking at the distribution of all mutations or groups of mutations according to 
type, indicate that exons 5–7, encoding the heavy chain region of the cathepsin C 
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protein, is the most important region for genetic screening of patients with Papillon-
Lefèvre syndrome. Approximately half 53% (n=40) of the all 75 mutations are located 
within this region. Three types mutations accounted for 93% (n=61) of CTSC gene 
mutations: missense 53% (n=41), nonsense 23% (n=17) and frameshift 17% (n=13). In 
addition, the majority of missense, nonsense and frameshift mutations occur in exons 5–
7. 
 
4.6. Genotype–phenotype correlations 
 
In general, no strict genotype–phenotype correlations have been identified for 
Papillon-Lefèvre syndrome. Analysis of CTSC mutation location (i.e., within or outside 
the coding regions) suggested that mutations located outside coding regions are more 
likely to be associated with transgression of the lesions (Hart et al., 2000a), although this 
hypothesis has not been confirmed (Selvaraju et al., 2003; de Haar et al., 2004; Hewitt et 
al., 2004). It was also suggested that CTSC gene mutations with little functional 
consequences are putative causes of more common types of early-onset periodontal 
disease (Hart et al., 2000c), but this observation has also not been confirmed (Hewitt et 
al., 2004). 
Mutations in the CTSC gene can lead to the development of Haim-Munk 
syndrome or aggressive periodontitis type 1 as well as Papillon-Lefèvre syndrome. The 
common characteristic of these three entities is periodontal inflammation (Hart et al., 
2000b; Hewitt et al., 2004; Cury et al., 2005). While all three diseases involve tooth 
abnormalities, Papillon-Lefèvre syndrome and Haim-Munk syndrome also involve 
characteristic skin symptoms of palmoplantar hyperkeratosis (Hart et al., 2000b; Hewitt 
et al., 2004; Cury et al., 2005). Haim-Munk syndrome is further characterized by 
arachnodactly, acroosteolysis, pesplanus and onychogryphosis (Hart et al., 2000b; 
Hewitt et al., 2004; Cury et al., 2005). 
Several reports indicate that identical mutations of the CTSC gene can give rise 
to multiple different phenotypes: the c.1040A>G p.Tyr347Cys missense mutation can 
lead either Papillon-Lefèvre syndrome or aggressive periodontitis type 1 (Toomes et al., 
1999; Hart et al., 2000c; Hewitt et al., 2004) and the c.145C>T p.Gln49X nonsense 
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mutation results either in Haim-Munk syndrome or Papillon-Lefèvre syndrome 
(Selvaraju et al., 2003; Rai et al., 2010). Hart et al. (2001) reported that the c.857A>G 
p.Gln286Arg missense mutation can also contribute to the development of Haim-Munk 
syndrome and Papillon-Lefèvre syndrome (Hart et al., 2000b). Variable expression of 
the phenotype associated with the CTSC mutation may reflect the influence of other 
genetic and/or environmental factors (Hart et al., 2000a). 
 
4.7. Future prospects 
 
To date, the comparison of CTSC gene mutations has not yet resulted in the 
identification of genotype–phenotype correlations. Future efforts might provide insight 
into these correlations and elucidate the mechanism of the different phenotypic variants 
of Papillon-Lefèvre syndrome. It is necessary to promote both better awareness of the 
Papillon-Lefèvre syndrome and its phenotypic variants. The availability of the extended 
clinical findings from CTSC mutation carriers is critical for furthering both our 
understanding of the disease and the development of causative therapies that will be 
more specific and effective than the symptomatic treatments currently available for 
patients with Papillon-Lefèvre syndrome and its allelic variants. 
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5. Summary 
 
In this study, my aim was to investigate Christ-Siemens-Touraine syndrome, 
Papillon-Lefèvre syndrome and its allelic variants: Haim-Munk syndrome and 
aggressive periodontitis type 1. The common phenotypic feature of these rare entities is 
the presence of severe periodontitis. In aggressive periodontitis type 1, there is no further 
associated symptom, while in Papillon-Lefèvre syndrome and in Haim-Munk syndrome 
there are some further skin symptoms (Table I.).  
Before the huge advances in the development of the sequencing methods these 
entities based on their clinical symptoms were separated as different diseases. With 
decoding the human genome in the former decade a lot of disease-causing genetic 
variations have been discovered. These findings elucidated the genetic background of 
Christ-Siemens-Touraine syndrome, Papillon-Lefèvre syndrome, Haim-Munk syndrome 
and aggressive periodontitis type 1 and it turned out that they are the results of the 
mutations in the EDA1 and CTSC genes. Since the same mutation can lead to the 
development of different phenotypes, it was concluded that Papillon-Lefèvre syndrome, 
Haim-Munk syndrome and aggressive periodontitis type 1 are not different entities, but 
the allelic variation of the same disease.  
In this study, I have investigated a Hungarian pedigree with Christ-Siemens-
Touraine syndrome, two Hungarian pedigrees and two sporadic cases with Papillon-
Lefèvre syndrome. Besides complete clinical care including dental and dermatological 
examinations and interventions, I have initiated the genetic screening and the 
identification of the underlying causative abnormalities on the EDA1 and CTSC gene. 
These investigations had great significance for the patients because with the 
identification of the causative abnormalities family planning can be helped with prenatal 
diagnostic interventions. In long term, my aim is also to raise the awareness of dentists 
and other physicians for rare diseases and to create an efficient multidisciplinary team to 
the clinical workup for these patients.  
 
44 
 
 
6. Acknowledgements 
 
I would like to thank to Dr. Nikoletta Nagy and to Prof. Dr. Katalin Nagy their 
great supervising activity.  
Special thanks to all my colleagues for their kind help in the dental workup of the 
patients. 
I am grateful to Dr. Nikoletta Nagy and to Dr. Zsanett Csoma for the 
dermatological examinations of the patients. 
Special thanks to Dr. Beáta Fábor and her colleagues at the Mór Kaposi teaching 
Hospital (Kaposvár) for enrolling two pateints into the study. 
I would like to thank to Prof. Dr. Márta Széll for the opportunity to perform the 
genetic investigations of this study in the molecular laboratory of the Department of 
Medical Genetics Institute, University of Szeged.  
I am grateful to all the patients, symptomless family members and control 
individuals for participated in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
 
7. Electronic database information 
 
Ensemble Genome Browser, (for the wild type sequencing data of the human 
genome, for the gene variation database regarding disease-causing and non-causing 
alterations and for the taxonomy analysis of the identified mutation on the GLRA1 
gene). www.ensemble.org 
   
Online Mendelian Inheritance in Man, (for the detailed informations on the 
genetics, inheritance, clinical features and identified mutations in monogenic 
neurogenetic disorders). www.omim.org 
 
Orphanet Database, (the collection and detailed description of rare diseases). 
www.orpha.net 
 
UCSC Genome Bioinformatics, (for the design of specific primers used to 
amplify the sequenced regions of the genes). http://genome.ucsc.edu/ 
 
Pubmed, (for the literature search to identify the previously published cases). 
http://www.ncbi.nlm.nih.gov/pubmed 
 
 
 
 
 
 
 
 
 
 
46 
 
 
8. References 
 
1. Adkison AM, Raptis SZ, Kelley DG, Pham CT. 2002. Dipeptidyl peptidase I activates 
neutrophil-derived serine proteases and regulates the development of acute 
experimental arthritis. J Clin Invest 109:363-371. 
 
2. Allende LM, García-Pérez MA, Moreno A, Corell A, Carasol M, Martínez-Canut P, 
Arnaiz-Villena A. 2001.Cathepsin C gene: First compound heterozygous patient with 
Papillon-Lefevre syndrome and a novel symptomless mutation. Hum Mutat 17:152-
153. 
 
3. Allende LM, Moreno A, de Unamuno P. 2003.A genetic study of cathepsin C gene in 
two families with Papillon-Lefevre syndrome. Mol Genet Metab 79:146-148. 
 
4. Bullon P, Pascual A, Fernandez-Novoa MC, Borobio MV, Muniain MA, Camacho F. 
1993. Late onset Papillon-Lefèvre syndrome? A chromosomic, neutrophil function 
and microbiological study. J Clin Periodontol 20:662-667. 
 
5. Cagli NA, Hakki SS, Dursun R, Toy H, Gokalp A, Ryu OH, Hart PS, Hart TC. 2005. 
Clinical, genetic, and biochemical findings in two siblings with Papillon-Lefevre 
syndrome. J Periodontol 76:2322-2329. 
 
6. Castori M, Madonna S, Giannetti L, Floriddia G, Milioto M, Amato S, Castiglia D. 
2009. Novel CTSC mutations in a patient with Papillon-Lefèvre syndrome with 
recurrent pyoderma and minimal oral and palmoplantar involvement. Br J Dermatol 
160:881-883. 
 
7. Cigić B, Krizaj I, Kralj B, Turk V, Pain RH. 1998. Stoichiometry and heterogeneity of 
the pro-region chain in tetrameric human cathepsin C. Biochim Biophys Acta 
1382:143-150. 
 
47 
 
 
8. Cury VF, Costa JE, Gomez RS, Boson WL, Loures CG, De ML. 2002.A novel mutation 
of the cathepsin C gene in Papillon-Lefevre syndrome. J Periodontol 75:307-312. 
 
9. Cury VF, Gomez RS, Costa JE, Friedman E, Boson W, De Marco L. 2005. A 
homozygous cathepsin C mutation associated with Haim-Munk syndrome. Br J 
Dermatol 152:353-356. 
 
10. Cluzeau C, Hadj-Rabia S, Jambou M, Mansour S, Guigue P, Masmoudi S, Bal E, 
Chassaing N, Vincent MC, Viot G, Clauss F, Manière MC, Toupenay S, Le Merrer 
M, Lyonnet S, Cormier-Daire V, Amiel J, Faivre L, de Prost Y, Munnich A, 
Bonnefont JP, Bodemer C, Smahi A. 2011. Only four genes (EDA1, EDAR, 
EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal 
dysplasia cases. Hum Mutat 32:70–72.  
 
11. Dalgic B, Bukulmez A, Sari S. 2011. Eponym: Papillon-Lefevre syndrome. Eur J 
Pediatr 170:689-691. 
 
12. de Haar SF, Jansen DC, Schoenmaker T, De Vree H, Everts V, Beertsen W. 2004. Loss-
of-function mutations in cathepsin C in two families with Papillon-Lefevre syndrome 
are associated with deficiency of serine proteinases in PMNs. Hum Mutat 23:524. 
 
13. de Haar SF, Mir M, Nguyen M, Kazemi B, Ramezani GH, Everts V, Beertsen W. 2005. 
Gene symbol: CTSC. Disease: Papillon-Lefevre syndrome. Hum Genet 116:545. 
 
14. Dhadke SV, Kulkarni PM, Dhadke VN, Deshpande NS, Wattamwar PR. 2006. Papillon 
Lefevre syndrome. J Assoc Physicians India 54:246-247. 
 
15. Dhanrajani PJ. 2009. Papillon-Lefevre syndrome: clinical presentation and a brief 
review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:e1-e7. 
 
48 
 
 
16. Dolenc I, Turk B, Pungercic G, Ritonja A, Turk V. 1995. Oligomeric structure and 
substrate induced inhibition of human cathepsin C. J Biol Chem 270:21626-21631. 
 
17. Fardal O, Drangsholt E, Olsen I. 1998. Palmar plantar keratosis and unusual periodontal 
findings: observations from a family of 4 members. J Clin Periodontol 25:181-184. 
 
18. Ezer S, Bayes M, Elomaa O, Schlessinger D, Kere J. 1999. Ectodysplasin is a 
collagenous trimeric type II membrane protein with a tumor necrosis factor-like 
domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of 
cells. Hum Mol Genet 8:2079–2086. 
 
19. Farkas K, Paschali E, Papp F, Vályi P, Széll M, Kemény L, Nagy N, Csoma Z. 2013. A 
novel seven-base deletion of the CTSC gene identified in a Hungarian family with 
Papillon-Lefèvre syndrome. Arch Dermatol Res 305:453-455. 
 
20. Fete M, Hermann J, Behrens J, Huttner KM. 2014. X-linked hypohidrotic ectodermal 
dysplasia (XLHED): Clinical and diagnostic insights from an international patient 
registry. Am J Med Genet A 164:2437-2442. 
 
21. Fischer J, Blanchet-Bardon C, Prud'homme JF, Pavek S, Steijlen PM, Dubertret L, 
Weissenbach J. 1997. Mapping of Papillon-Lefevre syndrome to the chromosome 
11q14 region. Europ J Hum Genet 5:156-160. 
 
22. Gorlin RJ, Sedano H, Anderson VE. 1964. The syndrome of palmar-plantar 
hyperkeratosis and premature periodontal destruction of the teeth: a clinical and 
genetic analysis of the Papillon-Lefevre syndrome. J Pediat 65:895-908. 
 
23. Haneke E. 1979. The Papillon-Lefevre syndrome: keratosis palmoplantaris with 
periodontopathy: report of a case and review of the cases in the literature. Hum Genet 
51:1-35. 
 
49 
 
 
24. Hart PS, Pallos D, Zhang Y, Sanchez J, Kavamura I, Brunoni D, Hart TC. 2002. 
Identification of a novel cathepsin C mutation (p.W185X) in a Brazilian kindred with 
Papillon-Lefevre syndrome. Mol Genet Metab 76:145-147. 
 
25. Hart PS, Zhang Y, Firatli E, Uygur C, Lotfazar M, Michalec MD, Marks JJ, Lu X, 
Coates BJ, Seow WK, Marshall R, Williams D, et al. 2000a. Identification of 
cathepsin C mutations in ethnically diverse Papillon-Lefevre syndrome patients. J 
Med Genet 37:927-932. 
 
26. Hart TC, Bowden DW, Ghaffar KA, Wang W, Cutler CW, Cebeci I, Efeoglu A, Firatli 
E. 1998. Sublocalization of the Papillon-Lefevre syndrome locus on 11q14-q21.Am J 
Med Genet 79:134-139. 
 
27. Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, Zhang Y, 
Firatli E. 1999. Mutations of the cathepsin C gene are responsible for Papillon-
Lefevre syndrome. J Med Genet 36:881-887. 
 
28. Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, 
ZlotogorskiA, Shapira L, Soskolne WA. 2000b. Haim-Munk syndrome and Papillon-
Lefevre syndrome are allelic mutations in cathepsin C. J Med Genet 37:88-94. 
 
29. Hart TC, Hart PS, Michalec MD, Zhang Y, Marazita ML, Cooper M, Yassin OM, 
Nusier M, Walker S. 2000c. Localisation of a gene for prepubertal periodontitis to 
chromosome 11q14 and identification of a cathepsin C gene mutation. J Med Genet 
37:95-101. 
 
30. Hewitt C, McCormick D, Linden G, Turk D, Stern I, Wallace I, Southern L, Zhang L, 
Howard R, Bullon P, Wong M, Widmer R, et al. 2004. The role of cathepsin C in 
Papillon-Lefevre syndrome, prepubertal periodontitis, and aggressive periodontitis. 
Hum Mutat 23:222-228. 
 
50 
 
 
31. Hewitt C, Wu CL, Hattab FN, Amin W, Ghaffar KA, Toomes C, Sloan P, Read AP, 
James JA, Thakker NS. 2004. Coinheritance of two rare genodermatoses (Papillon-
Lefevre syndrome and oculocutaneous albinism type 1) in two families: A genetic 
study. Br J Dermatol 151:1261-1265. 
 
32. Jouary T, Goizet C, Coupry I, Redonnet-Vernhet I, Levade T, Burgelin I, Toutain A, 
Delaporte E, Douillard C, Lacombe D, Taieb A, Arveiler B. 2008. Detection of an 
intragenic deletion expands the spectrum of CTSC mutations in Papillon-Lefèvre 
syndrome. J Invest Dermatol 128:322-325. 
 
33. Kelsall D. 2013. With a disease for every day, who will care for the orphans? CMAJ 
185:1475. 
 
34. Kinyó A, Vályi P, Farkas K, Nagy N, Gergely B, Tripolszki K, Török D, Bata-Csörgő 
Z, Kemény L, Széll M. 2014. A newly identified missense mutation of the EDA1 
gene in a Hungarian patient with Christ-Siemens-Touraine syndrome. Arch Dermatol 
Res 306:97-100.  
 
35. Kobayashi T, Sugiura K, Takeichi T, Akiyama M. 2013. The novel CTSC homozygous 
nonsense mutation p.Lys106X in a patient with Papillon-Lefèvre syndrome with all 
permanent teeth remaining at over 40 years of age.Br J Dermatol. 
 
36. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. 2010. Neutrophil elastase, proteinase 
3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 62:726-
759. 
 
37. Kosem R, Debeljak M, RepičLampret B, Kansky A, Battelino T, TrebušakPodkrajšek 
K. 2012. Cathepsin C gene 5'-untranslated region mutation in papillon-lefèvre 
syndrome. Dermatology 225:193-203. 
 
51 
 
 
38. Kurban M, Cheng T, Wajid M, Kiuru M, Shimomura Y, Christiano AM. 2010. A novel 
mutation in the cathepsin C gene in a Pakistani family with Papillon-Lefevre 
syndrome. J Eur Acad Dermatol Venereol 24:967-969. 
 
39. Kurban M, Wajid M, Shimomura Y, Bahhady R, Kibbi AG, Christiano AM. 2009. 
Evidence for a founder mutation in the cathepsin C gene in three families with 
Papillon-Lefèvre syndrome. Dermatology 219:289-294. 
 
40. Laass MW, Hennies HC, Preis S, Stevens HP, Jung M, Leigh IM, Wienker TF, Reis A. 
1997. Localisation of a gene for Papillon-Lefèvre syndrome to chromosome 11q14-
q21 by homozygosity mapping. Hum Genet 101:376-382. 
 
41. Lefèvre C, Blanchet-Bardon C, Jobard F, Bouadjar B, Stalder JF, Cure S, Hoffmann A, 
Prud'Homme JF, Fischer J. 2001. Novel point mutations, deletions, and 
polymorphisms in the cathepsin C gene in nine families from Europe and North 
Africa with Papillon-Lefe`vre syndrome. J Invest Dermatol 117:1657–1661. 
 
42. Lexner MO, Bardow A, Hertz JM, Nielsen LA, Kreiborg S. 2007. Anomalies of tooth 
formation in hypohidrotic ectodermal dysplasia. Int J Paediatr Dent 17:10–18. 
 
43. Li S, Li J, Cheng J, Zhou B, Tong X, Dong X, Wang Z, Hu Q, Chen M, Hua ZC. 2008. 
Non-syndromic tooth agenesis in two Chinese families associated with novel 
missense mutations in the TNF domain of EDA (ectodysplasin A). PLoS ONE 
3:e2396. 
 
44. Lundgren T, Renvert S. 2004. Periodontal treatment of patients with Papillon-Lefe`vre 
syndrome: a 3-year follow-up. J Clin Periodontol 31:933–938. 
 
45. Nakajima K, Nakano H, Takiyoshi N, Rokunohe A, Ikenaga S, Aizu T, Kaneko T, 
Mitsuhashi Y, Sawamura D. 2008. Papillon-Lefe`vre syndrome and malignant 
52 
 
 
melanoma: a high incidence of melanoma development in Japanese palmoplantar 
keratoderma patients. Dermatology 217:58–62. 
46. Nakano A, Nomura K, Nakano H, Ono Y, LaForgia S, Pulkkinen L, Hashimoto I, Uitto 
J. 2001. Papillon-Lefevre syndrome: mutations and polymorphisms in the cathepsin C 
gene. J Invest Dermatol 116:339-343. 
 
47. Nitta H, Wara-Aswapati N, Lertsirivorakul J, Nakamura T, Yamamoto M, Izumi Y, 
Nakamura T, Ishikawa I. 2005. A novel mutation of the cathepsin C gene in a Thai 
family with Papillon-Lefevre syndrome. J Periodontol 76:492-496. 
 
48. Noack B, Görgens H, Hempel U, Fanghänel J, Hoffmann T, Ziegler A, Schackert HK. 
2008. Cathepsin C gene variants in aggressive periodontitis. J Dent Res 87:958–963. 
 
49. Noack B, Gorgens H, Hoffmann T, Fanghanel J, Kocher T, Eickholz P, Schackert HK. 
2004. Novel mutations in the cathepsin C gene in patients with prepubertal aggressive 
periodontitis and Papillon-Lefevre syndrome. J Dent Res 83:368-370. 
 
50. Noack B, Görgens H, Schacher B, Puklo M, Eickholz P, Hoffmann T, Schackert HK. 
2008. Functional cathepsin C mutations cause different Papillon-Lefèvre syndrome 
phenotypes. J Clin Periodontol 35:311-316. 
 
51. Pallos D, Acevedo AC, Mestrinho HD, Cordeiro I, Hart TC. 2010. Novel cathepsin C 
mutation in a Brazilian family with Papillon-Lefèvre syndrome: case report and 
mutation update. J Dent Child (Chic) 77:36-41. 
 
52. Papillon PH, Lefèvre P. 1924. Deuxcas de kératodermiepalmaire et 
plantairesymétriquefamiliale (maladie de Meleda) chez le frère et la soeur. 
Coexistence dans les deuxcasd’altérations dentaires graves. Bulletin de la Société 
française de dermatologie et de vénéorologie, Paris 31:82-87. 
 
53 
 
 
53. Paris A, Strukelj B, Pungercar J, Renko M, Dolenc I, Turk V. 1995. Molecular cloning 
and sequence analysis of human preprocathepsin C. FEBS Lett 369:326-330. 
 
54. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. 2004. Papillon-Lefevre 
syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin 
C⁄dipeptidyl peptidase I deficiency in humans. J Immunol 175:7277–7281. 
 
55. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. 2004. Papillon-Lefèvre 
syndrome: Correlating the molecular, cellular, and clinical consequences of cathepsin 
C/dipeptidyl peptidase I deficiency in humans. J Immunol 175:7277-7281. 
 
56. Piirilä H, Väliaho J, Vihinen M. 2006. Immunodeficiency mutation databases (IDbases). 
Hum Mutat 27:1200-1208. 
 
57. Pilger U, Hennies HC, Truschnegg A, Aberer E. 2003. Late-onset Papillon-Lefe`vre 
syndrome without alteration of the cathepsin C gene. J Am Acad Dermatol 
5(Suppl.):S240–S243. 
 
58. Pinheiro M, Freire-Maia N. 1979. Christ-Siemens-Touraine syndrome--a clinical and 
genetic analysis of a large Brazilian kindred. I. Affected females. II. Affected males. 
III. Carrier detection. Am J Med Genet 4:113-134.  
 
59. Rai R, Thiagarajan S, Mohandas S, Natarajan K, ShanmugaSekar C, Ramalingam S. 
2010. HaimMunk syndrome and Papillon Lefevre syndrome--allelic mutations in 
cathepsin C with variation in phenotype. Int J Dermatol 49:541-543. 
 
60. Romero-Quintana JG, Frías-Castro LO, Arámbula-Meraz E, Aguilar-Medina M, 
Dueñas-Arias JE, Melchor-Soto JD, Romero-Navarro JG, Ramos-Payán R. 2013. 
Identification of novel mutation in cathepsin C gene causing Papillon-Lefèvre 
Syndrome in Mexican patients. BMC Med Genet 14:7. doi: 10.1186/1471-2350-14-7. 
 
54 
 
 
61. Rouse C, Siegfried E, Breer W, Nahass G. 2004. Hair and sweat glands in families with 
hypohidrotic ectodermal dysplasia: further characterization. Arch Dermatol 140:850–
855. 
 
62. Selvaraju V, Markandaya M, Prasad PV, Sathyan P, Sethuraman G, Srivastava SC, 
Thakker N, Kumar A. 2003. Mutation analysis of the cathepsin C gene in Indian 
families with Papillon-Lefe`vre syndrome. BMC Med Genet 4:5. 
 
63. Tao R, Jin B, Guo SZ, Qing W, Feng GY, Brooks DG, Liu L, Xu J, Li T, Yan Y, He L. 
2006. A novel missense mutation of the EDA gene in a Mongolian family with 
congenital hypodontia. J Hum Genet 51:498–502.  
 
64. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, Hewitt C, Moynihan 
L, Roberts E, Woods CG, Markham A, Wong M, et al. 1999. Loss-of-function 
mutations in the cathepsin C gene result in periodontal disease and palmoplantar 
keratosis. Nat Genet 23:421–424. 
 
65. Turk D, Janjic V, Sitern I, Podobnik M, Lamba D, Dahl SW, Lauritzen C, Pedersen J, 
Turk V, Turk B. 2001. Structure of human dipeptidyl peptidase I (cathepsin C): 
exclusion domain added to an endopeptidase framework creates the machine for 
activation of granular serine proteases.  EMBO J 20:6570–6582. 
 
66. Wani AA, Devkar N, Patole MS, Shouche YS. 2006. Description of two new cathepsin 
C gene mutations in patients with Papillon-Lefevre syndrome. J Periodontol 77:233-
237. 
 
67. Wen X, Wang X, Duan X. 2012. High immunoglobulin E in a Chinese Papillon-Lefèvre 
syndrome patient with novel compound mutations of cathepsin C. J Dermatol 39:664-
665. 
 
55 
 
 
68. Yang Y, Bai X, Liu H, Li L, Cao C, Ge LJ. 2007. A novel mutation of cathepsin C gene 
in two Chinese patients with Papillon-Lefevre syndrome. Dent Res 86:755-758. 
 
69. Zhang Y, Hart PS, Moretti AJ, Bouwsma OJ, Fisher EM, Dudlicek L, Pettenati MJ, Hart 
TC. 2002. Biochemical and mutational analyses of the cathepsin c gene (CTSC) in 
three North American families with Papillon-Lefevre syndrome. Hum Mutat 20:75. 
 
70. Zhang Y, Lundgren T, Renvert S, Tatakis DN, Firatli E, Uygur C, Hart PS, Gorry MC, 
Marks JJ, Hart TC. 2001. Evidence of a founder effect for four cathepsin C gene 
mutations in Papillon-Lefevre syndrome patients. J Med Genet 38:96-101. 
 
 
 
 
56 
 
 
Appendix 
57 
 
 
Publication I 
58 
 
 
 
59 
 
 
 
60 
 
 
 
61 
 
 
 
62 
 
 
Publication II 
63 
 
 
 
64 
 
 
 
65 
 
 
 
66 
 
 
Publication III 
67 
 
 
 
68 
 
 
 
69 
 
 
 
70 
 
 
 
71 
 
 
 
72 
 
 
 
73 
 
 
 
74 
 
 
 
75 
 
 
 
76 
 
 
 
77 
 
 
 
78 
 
 
 
79 
 
 
Publication IV 
80 
 
 
81 
 
 
82 
 
 
83 
 
 
84 
 
 
85 
 
 
 
